Syneos Health

Large Pharma Clinical Development and Commercialization for Global Biopharmaceutical Leaders

Large pharmaceutical organizations require consistency, transparency and scalability. Syneos Health supports enterprise ...
syneoshealth

Strengthening Clinical Rigor in Psychedelic Development: Ensuring Patient Safety, Treatment Consistency and Operational Excellence

Psychedelic therapies are advancing toward potential regulatory review and commercialization, creating new expectations for how clinical programs are designed, executed and evaluated. Unlike ...
syneoshealth

Do Patients Need a Hub or a Better Patient Support Model?

Disruption in the patient services landscape is prompting biopharmaceutical manufacturers to reassess their patient support strategies. While maintaining continuity of care and minimizing operational ...
syneoshealth

Building Predictable Vaccine Trials: Five Drivers to Protect Endpoints

In a vaccine study, the right sites must be ready at the right time—and every potential endpoint event must be captured and documented. Delays in activation, gaps in surveillance or missing specimens ...
syneoshealth

RBQM for Emerging Biopharma: Owning What Matters Most

For emerging biopharmaceutical companies, risk-based quality management (RBQM) is more than a regulatory requirement. It is an opportunity to strengthen clinical trial oversight, protect timelines and ...
syneoshealth

Benchmarking Study Finds Clinical Trial Performance Is Shaped by Operating Model Design, Not Sourcing Strategy

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

Biopharma challenges leaders want to tackle

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

Editor’s Letter: Taking Talent to the Next Level

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

There Is No Such Thing as a Typical Biotech

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

Muaiad Kittaneh: Why “What’s Next” Isn’t Always What Oncology Needs For Innovation

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

Muaiad Kittaneh: Oncology Development Moving Beyond Traditional Protocol Execution

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

Mitigating Manufacturers’ Exposure to Us Mfn Policy Through European Repricing

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...